INDICATIONS AND USAGE
Halobetasol propionate cream, 0.05% is a super-high potency corticosteroid indictated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Treatment beyond two consecutive weeks is not recommended, and the total dosage should not exceed 50 g/week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis.
Use in children under 12 years of age is not recommended. As with other highly active corticosteroid, therapy should be discontinued when control has been achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary.
|
DOSAGE AND ADMINISTRATION
Apply a thin layer of halobetasol propionate cream, 0.05% to the affected skin once or twice daily, as directed by your physician, and rub in gently and completely.
Halobetasol propionate cream, 0.05% is a super-high potency topical corticosteroid; therefore, treatment should be limited to two weeks, and amounts greater than 50 g/wk should not be used. As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary.
Halobetasol propionate cream, 0.05% should not be used with occlusive dressings.
|
HOW SUPPLIED
Halobetasol propionate cream, 0.05% is supplied in the following tube sizes:
15 g (NDC 45802-129-35)
50 g (NDC 45802-129-32)
STORAGE
Store at 20 - 25°C (68 - 77°F) (See USP Controlled Room Temperature).
MADE IN ISRAEL
MANUFACTURED BY PERRIGO, YERUHAM, ISRAEL, 80500
DISTRIBUTED BY
PERRIGO®
ALLEGAN, MI 49010
Rev. 5/07
: 4C600 RC J2
|
